Carbogen AMCIS AG

Details

  • Number of employees
    200-500
  • Company Type
    Large Multi-national
About Carbogen AMCIS AG

Carbogen AMCIS AG is a leading global provider of integrated drug development and manufacturing services. With a strong focus on the pharmaceutical and biotechnology sectors, the company excels in delivering high-quality solutions tailored to meet the unique needs of its clients.

Founded with the vision of advancing healthcare through innovative technologies, Carbogen AMCIS AG has established itself as a trusted partner for companies looking to bring their products to market efficiently and effectively. The company offers a comprehensive range of services, including:

  • API Development: Specialising in the development of active pharmaceutical ingredients, Carbogen AMCIS AG ensures that all products meet stringent regulatory standards.
  • Formulation Services: The company provides expert formulation services to optimise drug delivery and enhance therapeutic efficacy.
  • Clinical Trial Material Production: Carbogen AMCIS AG supports clients by producing clinical trial materials that are essential for the successful progression of drug development.
  • Commercial Manufacturing: With state-of-the-art facilities, the company is equipped to handle large-scale commercial manufacturing, ensuring timely delivery and quality assurance.

Headquartered in the UK, Carbogen AMCIS AG operates globally, serving a diverse clientele that includes small biotech firms and large pharmaceutical corporations. The company prides itself on its commitment to quality, innovation, and customer satisfaction.

With a dedicated team of experts and a robust infrastructure, Carbogen AMCIS AG is well-positioned to support the evolving needs of the pharmaceutical industry. The company’s mission is to facilitate the development of life-saving therapies while maintaining the highest standards of safety and compliance.

>